Cochrane Reviews - by sub-topics 'Haematological Malignancies'

The Cochrane Collaboration
Cochrane Reviews

Advanced search

Explore

Other languages

search & browse

|

|

full list of all reviews

|

by country of author

|

Audio summaries | Evidence Aid summaries | Cochrane Methodology abstracts

by sub-topics:

For complete list (no sub-topics), click here - Browse by sub-topic (Review Group)

Can't find a review topic below covering your question or interest? Suggest one:

*

Consider types of interventions, problems or issues, and who might be affected. Example: Effects of surgical sphenoidal sinusitis treatments in young people.

To hide this form click here

*

= required

*

Why are you suggesting this topic?:

Example:
"This affects millions of people. Your search doesn't turn up any mention of it."

*

Name:

*

Role:

Organization:

Example:
University Hospital Freiburg

*

Country:

*

Email:

Your email address will be used to contact you, should our staff wish to followup on your suggestions. It will NOT be shared beyond this purpose.

Other contact details

More about privacy

Haematological Malignancies Group (60)

Acute Myeloid Leukaemia (1)

Cytosine arabinoside for the treatment of acute promyelocytic leukaemia (protocol stage)

Acute Lymphoblastic Leukaemia (2)

Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia (protocol stage)

Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia

Chronic Myeloid Leukaemia (0)

Chronic Lymphocytic Leukaemia (3)

Alemtuzumab for chronic lymphocytic leukaemia (protocol stage)

Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia (protocol stage)

Purine Antagonists for Chronic Lymphocytic Leukaemia

Non Hodgkin Lymphoma (10)

Alkylating agents for Waldenstrom's macroglobulinaemia

Chemotherapy alone vs. radiotherapy alone vs. chemotherapy plus radiotherapy in the primary treatment of localised non-Hodgkin's lymphoma (protocol stage)

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data (protocol stage)

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults

Interferon-alpha for maintenance of follicular lymphoma (protocol stage)

Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults (protocol stage)

Rituximab as maintenance therapy for patients with follicular lymphoma

Therapeutic interventions for Burkitt's lymphoma in children

Multiple Myeloma (3)

Bisphosphonates in multiple myeloma

Early versus deferred treatment for early stage multiple myeloma

First-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma (protocol stage)

Hodgkin Lymphoma (5)

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin Lymphoma (protocol stage)

Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma (protocol stage)

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

Interventions for early stage Hodgkin's disease in children (withdrawn)

Myelodysplastic Syndrome (1)

Deferasirox for managing iron overload in patients with myelodysplastic syndrome (protocol stage)

Aplastic Anaemia (2)

First-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemia (protocol stage)

Hematopoietic Growth Factors in the Treatment of Acquired Aplastic Anemia (protocol stage)

Other Haematological Diseases (2)

Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia

Steroids versus Immunoglobulin for Pediatric Acute Idiopathic Thrombocytopenic Purpura (protocol stage)

Haematopoietic Growth Factors (10)

Antibiotics plus colony stimulating factors (CSFs) versus CSFs alone and antibiotics plus CSFs versus no prophylaxis for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation (protocol stage)

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation (protocol stage)

Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors

Colony stimulating factors for afebrile neutropenia in cancer patients (protocol stage)

Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia

Erythropoietin or Darbepoetin for patients with cancer

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

Hematopoietic Growth Factors in the Treatment of Acquired Aplastic Anemia (protocol stage)

Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy

Stem Cell Transplantation (11)

Allogeneic SCT (4)

Allogeneic peripheral blood stem cells transplantation versus bone marrow transplantation for the therapy of hematological malignancies (protocol stage)

Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation (protocol stage)

Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation

First-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemia (protocol stage)

Autologous SCT (5)

Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia (protocol stage)

First-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma (protocol stage)

High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data (protocol stage)

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults

Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults (protocol stage)

Donors (1)

Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors

Supportive Care in SCT (1)

Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation

Supportive Care in Haematological Diseases (6)

Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies (protocol stage)

Bisphosphonates in multiple myeloma

Deferasirox for managing iron overload in patients with myelodysplastic syndrome (protocol stage)

Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation

Vaccines for prophylaxis of viral infections in patients with hematological malignancies (protocol stage)

Paediatric Haematology/Oncology (4)

Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia

Interventions for early stage Hodgkin's disease in children (withdrawn)

Steroids versus Immunoglobulin for Pediatric Acute Idiopathic Thrombocytopenic Purpura (protocol stage)

Therapeutic interventions for Burkitt's lymphoma in children

top of page | contact us | about this site | disclaimer | privacy